Articles

dow agro logo entrance

DuPont CEO in position to decide fate of Dow Agro

The Dow Chemical-DuPont merger throws into doubt what will happen to the 1,500 people who work at Dow AgroSciences’ Indianapolis headquarters, especially since executives plan $1.3 billion in savings from combining ag units.

Read More

Dow, DuPont agree to combine in historic merger of equals

Dow and DuPont plan to divide the combined company into three publicly traded businesses, one of which would focus on agricultural products including herbicides and genetically modified seeds—the core business of Dow's Indianapolis-based Dow AgroSciences unit. DuPont also has a large ag unit.

Read More

Lilly separating manufacturing of animal health drugs

Eli Lilly and Co. is in the process of separating the manufacturing of its animal health drugs from the facilities used to make its traditional pharmaceuticals, a move that potentially could make it easier to spin off the division one day.

Read More

All of a sudden, HIP 2.0 has a cloudy future

Gov. Mike Pence’s expanded version of the Healthy Indiana Plan looked secure after winning approval from the Obama administration in January. But now it faces threats from both liberals and conservatives.

Read More
rop-anthem-120715-2col.jpg

Investors betting no on Anthem mega-deal

Lots of investors are betting health insurance giants Anthem Inc. and Cigna Corp. won’t ever make it to the altar—an outlook driven by concerns antitrust regulators or other obstacles will prevent consummating the $45 billion deal.

Read More

UnitedHealth says it should have waited on Obamacare

UnitedHealth Group Inc. should have stayed out of Obamacare’s new individual markets longer, the CEO of the health insurer said Tuesday. The company expects losses from the plans this year and next to total more than a half-billion dollars.

Read More